Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.7042
+0.1210 (20.75%)
At close: Oct 27, 2026, 4:00 PM EDT
0.7200
+0.0158 (2.24%)
After-hours: Oct 27, 2026, 7:30 PM EDT
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $60.75 million as of October 27, 2026. It is the 28,677th most valuable company in the world and the 4,471st biggest in the United States. Its market cap has increased by 80.80% in one year.
Market Cap
60.75M
Enterprise Value
20.10M
1-Year Change
80.80%
Global Rank
Country Rank
#4,471 United States
Category
ChartMarket Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.90M to $60.75M, a decrease of -61.77%. That is a compound annual growth rate of -9.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 60.70M | 99.02% |
| Dec 31, 2025 | 30.50M | -38.76% |
| Dec 31, 2024 | 49.80M | 260.87% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
| Jun 29, 2017 | 158.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alps Group | 54.51M |
| MiNK Therapeutics | 53.22M |
| Clene | 53.16M |
| Pliant Therapeutics | 52.62M |
| Caribou Biosciences | 52.53M |
| Eloxx Pharmaceuticals | 52.51M |
| Connect Biopharma Holdings | 52.36M |
| Gain Therapeutics | 50.19M |